METHOD FOR PREVENTING DEVELOPING THROMBOCYTOPENIA IN PATIENTS SUFFERING CHRONIC HEPATITIS C COMBINED WITH Helicobacter pylori INFECTION AND RECEIVING COMBINED ANTIVIRAL THERAPY Russian patent published in 2014 - IPC A61K31/431 A61K31/4439 A61K31/7048 A61P7/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to gastroenterology and infectious diseases, and concerns the prevention of developing thrombocytopenia in the patients suffering chronic hepatitis C (CHC) in a combination with Helicobacter pylori infection and receiving a combined antiviral therapy (CAVT). For this purpose, the beginning of the CAVT is preceded by a 10-14-day eradication therapy according to the schedule: a proton pump inhibitor in a standard dose twice a day + amoxicillin 500 mg 4 times a day or 1000 mg twice a day + clarithromycin 500 mg twice a day. The CAVT starts 2 weeks after the completion of the eradication therapy.

EFFECT: method provides reducing a risk of developing or progressing thrombocytopenia in the patients with chronic hepatitis C with underlying CAVT.

4 cl, 1 dwg